2026 ASCO Breast Cancer Highlights: SENOMAC - Takeaways - MDSpire

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

October 15, 2026

Dana-Farber

Share

1

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial.
2

The discussion focuses on patients with early breast cancer and limited lymph node involvement.
3

SENOMAC examines whether some patients can safely avoid additional axillary surgery.
4

The provided context does not report SENOMAC trial results.
5

The provided context does not specify the trial’s design, outcomes, or patient eligibility criteria.